Enhanced MRI reveals early benefits of statin therapy
This article was originally published in Clinica
Using an enhanced MRI technique in patients with atherosclerosis could help doctors detect the benefits of cholesterol-lowering therapy far earlier than previous imaging techniques have allowed. So say US researchers who found that transoesophageal MRI combined with standard surface MRI allowed them to measure the success of Zocor (simvastatin) in reducing plaque just six months after therapy began. Traditionally, MRI only reveals results at one or two years post-therapy.